Home About Privacy Policy Contact Degree Programs
by matt - no comments
CompuMed Enables Mobile Telemedicine for All

Cardiologists Interpreting ECGs from AliveCor Heart Monitor System


PRESS RELEASE: LOS ANGELES, CA (11/19/2013) – CompuMed, Inc. (OTCPink: CMPD), the leaders in providing enterprise telemedicine solutions, has begun interpreting electrocardiograms (ECGs) that are generated from the revolutionary AliveCor Heart Monitor System.

AliveCor patients now have instant access to CompuMed’s network of U.S. Board-Certified cardiologists.  Through the AliveECG app., AliveCor patients can request real-time interpretations of single-channel electrocardiogram (ECG) rhythms. CompuMed cardiologists are providing AliveCor patients with clinical ECG rhythm reports within 24 hours.

“Clinically speaking, the ability for CompuMed and AliveCor to provide patients with real-time access to Board-Certified cardiologists through the AliveECG app. has the potential to dramatically improve patient care. This solution enables virtually anyone, regardless of their location, to leverage the expertise of top cardiologists,” said Dr. David Frisch, Medical Director of CompuMed.  Doctor Frisch is an Associate Professor of Clinical Medicine at UCLA’s David Geffen School of Medicine, Director of the Center for Heart Attack and Stroke Prevention, and a founding board member and director of the Cedars-Sinai Physicians Association.

“We are thrilled to be partnering with AliveCor to deliver top clinical care at the push of button by leveraging our network of U.S. Board-Certified cardiologists,” said W. Scott Rombach, CompuMed’s President and CEO.

“We are delighted to be working with CompuMed to help patients manage their heart health”, said Euan Thomson, CEO of AliveCor.  “With this partnership, patients and their physicians now have direct access to Board-Certified cardiologists whenever and wherever using the AliveECG app. This 24/7 connectivity between patients and expert medical services takes mobile health to the next level.”

CompuMed’s Enterprise Telemedicine Solutions provide the highest level of clinical care to patients by enabling real-time access to Board-Certified specialists.  The company’s open architecture delivers end-to-end, cloud-based telemedicine solutions that are fully integrated with world-class medical devices.

The AliveCor Heart Monitor is the only FDA-cleared mobile ECG recorder that supports both iPhone and Android compatible smartphones.  This device is available for purchase in the United States by medical professionals and patients with prescriptions.

About AliveCor, Inc.

AliveCor, Inc., a privately held company headquartered in San Francisco, wants everyone to have their heart health at their fingertips. The company is dedicated to improving the lives of individuals around the world by making vital health signs easily visible, actionable and affordable. AliveCor’s tools and services help patients and physicians manage health and connect with each other anytime, anywhere.

About CompuMed, Inc.

CompuMed, Inc. (OTCPink: CMPD) Enterprise Telemedicine Solutions provide patients with the highest level of clinical care at reduced costs. Its telecardiology and teleradiology offerings provide direct access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices.  The company has been in business over 26 years and services over 1,000 clinical settings.  CompuMed is headquartered in Los Angeles, CA. Visit CompuMed at www.compumed.net.

Forward-Looking Statements

Statements contained in this report, such as statements about revenue, operations, and earnings growth and other financial results are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including statements concerning the Company’s plans, objectives, expectations and intentions are based largely on management’s expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These statements are subject to uncertainties and risks including, without limitation, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks identified in the Company’s filings with the Securities and Exchange Commission and OTC Pink operated by OTCMarkets. All such forward-looking statements are expressly qualified by these cautionary statements. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect events, conditions or circumstances on which any such statement is based after the date hereof, except as required by law.

CompuMed, Inc. Investor Relations: investorrelations@compumed.net or (310) 258-5000 x117

5777 W. Century Blvd

Suite 360

Los Angeles, California 90045